CannaPharmaRX, Inc. (CPMD) Stock Price & Growth Analysis

Quote Panel

Updated September 17, 2025

1W -3.33 % 1M -9.38 % 3M -9.38 % 1Y -67.05 %

Key Metrics

Market Cap
1.92M
Shares Outstanding
662.50M
Share in Float
615.77M
Dividende
0

Earning Date
No Data
Price Target
0.0029
Average Volume
157334
Beta
0.51

Range
0.0001-0.011
Industry
Drug Manufacturers - Specialty & Generic
Website
https://www.cannapharmarx.com
Sector
Healthcare

Quote Panel

Updated September 17, 2025

1W % 1M % 3M % 1Y %

Key Metrics

Market Cap
Shares Outstanding
Share in Float
Dividende

Earning Date
No Data
Price Target
Average Volume
Beta

Range
Industry
Website
Sector

Fundamentals

N/A

P/E Ratio

1.41x

P/S Ratio

N/Ax

P/B Ratio

N/A

Debt/Equity

-415.6%

Net Margin

$-0.0

EPS

How CPMD compares to sector?

P/E Ratio

Fundamentals

Relative Strength

CPMD

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Relative Strength

CPMD

Sector

Top 5 RS in Group

Symbol	Company	RS	5-Day Perf.

Forecast

N/A

2025-Revenue

N/A

2025-EPS

N/A

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Price Target

N/A(N/A)

Number of analyst

N/A

Last analyst upgrade/downgrade

No Data Available

Forecast

Analyst rating

Last analyst upgrade/downgrade

Earnings Growth

YoY

Current

Estimates

Q1.23

N/A

-0.00
vs -0.01

Q2.23

N/A

-0.01
vs -0.01

Q3.23

N/A

-0.00
vs -0.01

Q4.23

+205%

0.02
vs -0.02

Q1.24

N/A

-0.03
vs -0.00

Q2.24

+182%

0.01
vs -0.01

Q3.24

+115%

0
vs -0.00

Q4.24

N/A

-0.01
vs 0.02

Q1.25

N/A

-0.00
vs -0.03

Q2.25

N/A

-0.00
vs 0.01

Sales Growth

YoY

Current

Estimates

Q1.23

NA vs NA

Q2.23

NA vs NA

Q3.23

NA vs NA

Q4.23

-100%

32 vs 25K

Q1.24

25.8K vs NA

Q2.24

NA vs NA

Q3.24

312.2K vs NA

Q4.24

+1506569%

482.1K vs 32

Q1.25

+1198%

335.3K vs 25.8K

Q2.25

231.6K vs NA

Return on Equity

QoQ

Q1.23

+8%

0.08
vs 0.21

Q2.23

+9%

0.09
vs 0.08

Q3.23

+3%

0.03
vs 0.09

Q4.23

-62%

-0.62
vs 0.03

Q1.24

+50%

0.5
vs -0.62

Q2.24

-32%

-0.32
vs 0.5

Q3.24

-1%

-0.01
vs -0.32

Q4.24

+19%

0.19
vs -0.01

Q1.25

+3%

0.03
vs 0.19

Q2.25

+6%

0.06
vs 0.03

Institutionnal Ownership

N/A

Q2.23

NA
vs NA

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Earnings Growth

YoY

Current

Estimates

Q1.23

N/A

-0.00
vs -0.01

Q2.23

N/A

-0.01
vs -0.01

Q3.23

N/A

-0.00
vs -0.01

Q4.23

+205%

0.02
vs -0.02

Q1.24

N/A

-0.03
vs -0.00

Q2.24

+182%

0.01
vs -0.01

Q3.24

+115%

0
vs -0.00

Q4.24

N/A

-0.01
vs 0.02

Q1.25

N/A

-0.00
vs -0.03

Q2.25

N/A

-0.00
vs 0.01

Sales Growth

YoY

Current

Estimates

Q1.23

NA vs NA

Q2.23

NA vs NA

Q3.23

NA vs NA

Q4.23

-100%

32 vs 25K

Q1.24

25.8K vs NA

Q2.24

NA vs NA

Q3.24

312.2K vs NA

Q4.24

+1506569%

482.1K vs 32

Q1.25

+1198%

335.3K vs 25.8K

Q2.25

231.6K vs NA

Return on Equity

QoQ

Q1.23

+8%

0.08
vs 0.21

Q2.23

+9%

0.09
vs 0.08

Q3.23

+3%

0.03
vs 0.09

Q4.23

-62%

-0.62
vs 0.03

Q1.24

+50%

0.5
vs -0.62

Q2.24

-32%

-0.32
vs 0.5

Q3.24

-1%

-0.01
vs -0.32

Q4.24

+19%

0.19
vs -0.01

Q1.25

+3%

0.03
vs 0.19

Q2.25

+6%

0.06
vs 0.03

Institutionnal Ownership

N/A

Q2.23

NA
vs NA

Q3.23

NA
vs NA

Q4.23

NA
vs NA

Q1.24

NA
vs NA

Q2.24

NA
vs NA

Q3.24

NA
vs NA

Q4.24

NA
vs NA

Q1.25

NA
vs NA

Q2.25

NA
vs NA

Q3.25

NA
vs NA

Company Description

0.00USD

N/A

1.41x

N/Ax

N/A

-415.6%

$-0.0

N/A

N/A

N/A

Earnings Growth

Latest News

Latest News

Earnings Growth

Latest News

N/A

N/A

N/A

Company Description

0.00USD

N/A

1.41x

N/Ax

N/A

-415.6%

$-0.0